Medicare Pass-Through Payment System Needs Revision, MedPAC Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Anti-emetics illustrate the problem with the policy of providing separate payments for drugs over $50, MedPAC says. CMS is urged to use the pass-through process for all categories. MedPAC endorses CMS' proposed reimbursement change for Aranesp and Epogen in end-stage renal disease.